Who We Are

Based in Shanghai, BioShin Limited is a biopharmaceutical company focused on the discovery, development and commercialization of novel, life-improving treatments for patients with neuro-immune diseases in China and the Asia-Pacific region. BioShin is the wholly owned subsidiary of Biohaven (NYSE:BHVN). Beyond its current research and development portfolio, BioShin’s strategic vision also includes partnering with biopharmaceutical companies, inside and outside China, that seek to discover, develop, and commercialize assets in the region. By bringing together promising assets and a diverse management team with international expertise, BioShin is growing a nimble organization with an entrepreneurial spirit to serve patients throughout the region.

Highly experienced team with industry and academic roots